Carotid artery stenosis medical therapy: Difference between revisions

Jump to navigation Jump to search
Charmaine Patel (talk | contribs)
No edit summary
Charmaine Patel (talk | contribs)
No edit summary
Line 22: Line 22:
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]===
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]===
# Treatment with a statin is recommended for all patients with atherosclerotic ECVD to lower lowdensity lipoprotein cholesterol to less than 100 mg/dL. (Level of Evidence: B)
# Treatment with a statin is recommended for all patients with atherosclerotic ECVD to lower lowdensity lipoprotein cholesterol to less than 100 mg/dL. (Level of Evidence: B)
 
===[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]===
 
# Treatment with a statin is reasonable for all patients with atherosclerotic ECVD who sustain ischemic stroke to reduce low-density lipoprotein cholesterol to a level less than or equal to 70 mg/dL. (Level of Evidence: B)
 
# If treatment with a statin does not achieve the goal, intensifying therapy with an additional drug from among those with evidence of improving outcomes can be effective. (Level of Evidence: B)
# For patients who do not tolerate statins, therapy with bile acid sequestrants and/or niacin is reasonable. (Level of Evidence: B)}}


==References==
==References==

Revision as of 20:58, 1 October 2012

Carotid artery stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carotid artery stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Testing Guidelines

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

MRA

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ACC/AHA Guideline Recommendations

Diagnostic Testing Guidelines Recommendation

Primary Prevention and Screening Guidelines Recommendations

Secondary Prevention Guidelines Recommendations

Selection of Patients for Carotid Revascularization

Periprocedural Management of Patients Undergoing Carotid Endarterectomy

Management of Patients Undergoing Carotid Artery Stenting

Restenosis After Carotid Endarterectomy or Stenting

Vascular Imaging in Patients With Vertebral Artery Disease

Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease

Occlusive Disease of the Subclavian and Brachiocephalic Arteries

Fibromuscular Dysplasia

Cervical Artery Dissection

Case Studies

Case #1

Carotid artery stenosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carotid artery stenosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carotid artery stenosis medical therapy

CDC on Carotid artery stenosis medical therapy

Carotid artery stenosis medical therapy in the news

Blogs on Carotid artery stenosis medical therapy

Directions to Hospitals Treating Carotid artery stenosis

Risk calculators and risk factors for Carotid artery stenosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Medical Therapy

Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Treatment of Hypertension (DO NOT EDIT)

Class I

  1. Antihypertensive treatment is recommended for patients with hypertension and asymptomatic atherosclerotic ECVD to maintain blood pressure (BP) less than 140/90 mmHg. (Level of Evidence: A)

Class IIa

Except during the hyperacute period, antihypertensive treatment is probably indicated in patients with hypertension and symptomatic atherosclerotic ECVD, but the benefit of treatment to a specific BP has not been established in relation to the risk of exacerbating cerebral ischemia. (Level ofEvidence: C)

Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease:Control of Hyperlipidemia (DO NOT EDIT)

Class I

  1. Treatment with a statin is recommended for all patients with atherosclerotic ECVD to lower lowdensity lipoprotein cholesterol to less than 100 mg/dL. (Level of Evidence: B)

Class IIa

  1. Treatment with a statin is reasonable for all patients with atherosclerotic ECVD who sustain ischemic stroke to reduce low-density lipoprotein cholesterol to a level less than or equal to 70 mg/dL. (Level of Evidence: B)
  2. If treatment with a statin does not achieve the goal, intensifying therapy with an additional drug from among those with evidence of improving outcomes can be effective. (Level of Evidence: B)
  3. For patients who do not tolerate statins, therapy with bile acid sequestrants and/or niacin is reasonable. (Level of Evidence: B)

References